ArticleJournal of clinical medicine2026

An Open Label, Cross-Over Phase 1 Study to Determine the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of Niclosamide Under Fed and Fasted Conditions in Healthy Volunteers.

Gary K Ostrander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.